Ticker LaunchIPO · TFFP
TFF Pharmaceuticals, Inc.
TFF Pharmaceuticals, Inc. (TFFP) priced its initial public offering on Oct 25, 2019 at $5.00 per share. At the IPO price its market capitalization was about $89.1M. National was lead-left underwriter. Greenberg Traurig advised the company and LKP Global Law advised the underwriters.
TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company developing drug products with its patented Thin Film Freezing platform, which aims to improve the solubility of poorly water-soluble drugs. It has not yet taken any candidate into human trials, focusing on formulation and animal testing.
- Status
- IPO
- Ticker
- TFFP
- Priced
- Oct 25, 2019
- IPO price
- $5.00
- Market cap at IPO price
- $89.1M
- First filed
- Aug 20, 2019
- Underwriters
- National
- Company counsel
- Greenberg Traurig
- Underwriters' counsel
- LKP Global Law
- Sector
- Biotech & pharma
- Country / state
- TX
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Aug 20, 2019
- Latest amendment Oct 11, 2019
- Final prospectus (424B4) Oct 25, 2019
- All filings on EDGAR CIK 1733413
Other Biotech & pharma IPOs in 2019
- Oyster Point Pharma, Inc.OYST · Oct 31, 2019 · $80M
- Phathom Pharmaceuticals, Inc.PHAT · Oct 28, 2019 · $181.7M
- Cabaletta Bio, Inc.CABA · Oct 25, 2019 · $74.8M
- Innate Pharma SAIPHA · Oct 18, 2019
- BioNTech SEBNTX · Oct 11, 2019 · $150M
- Vir Biotechnology, Inc.VIR · Oct 11, 2019 · $142.9M